Replenix Lip Therapy
- Product NDC
- 51326-102
- 11-digit product format
- 513260102
- Labeler code
- 51326
- Product ID
- 51326-102_cda6e73e-8e21-48d6-bd98-282e4a06ff32
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- homosalate
- Dosage form
- LIPSTICK
- Route
- TOPICAL
- Labeler
- Topiderm, Inc.
- Application
- M020
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2022-01-02
- Substance
- AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE
- Active strength
- 30; 150; 75; 50 mg/g; mg/g; mg/g; mg/g
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Replenix Lip Therapy
- Brand name suffix
- homosalate
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AVOBENZONE | 30 mg/g |
| HOMOSALATE | 150 mg/g |
| OCTINOXATE | 75 mg/g |
| OCTISALATE | 50 mg/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | G63QQF2NOX, V06SV4M95S, 4Y5P7MUD51, 4X49Y0596W |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51326-102-04 | Replenix Lip Therapyhomosalate | 4 g in 1 BOTTLE | LIPSTICK | 4 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51326-102 | REPLENIX LIP THERAPY HOMOSALATE (HOMOSALATE) LIPSTICK [TOPIDERM, INC.] | 5 | Current NDC, 1 package rows | 20230209_b60dc004-d713-47bc-a6e9-ea4783aa7019.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51326-102-04 | 51326010204 | 4 g in 1 BOTTLE (51326-102-04) | 4 g | 2022-01-02 | No | No | Historical |